Loading the map…
Activities of patent and copyright agents; other legal activities n.e.c. · Bury
Emedico
Emedico Limited
Private limited company registered in Bury, classed under “Activities of patent and copyright agents” and 1 other activity.
Headline figures
FY to Dec 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
1 finding from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Profit after tax | — | ||||
| Turnover | |||||
| Net assets | |||||
| Cash | |||||
| Employees | |||||
| Retained reserves |
Every figure for all 5 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Creditors due within a year | ||||
| Net current assets | ||||
| Ratios | ||||
| Cash ratioCash for every £1 owed within a year | ||||
2 balance-sheet lines and 1 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Questions people ask
›What does Emedico do?
Private limited company registered in Bury, classed under “Activities of patent and copyright agents” and 1 other activity.
›How much turnover does Emedico make?
Answered in the full report
›Is Emedico profitable?
Emedico's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Emedico?
Answered in the full report
›Where is Emedico based?
Its registered office is 82 Bolton Street, Bury, BL9 0LL, in Bury.
›When was Emedico founded?
Emedico Limited was incorporated on 29 January 2016.
›Is Emedico still trading?
The register lists Emedico Limited as active.